228
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Predictive Machine Learning Tool for Asthma Exacerbations: Results from a 12-Week, Open-Label Study Using an Electronic Multi-Dose Dry Powder Inhaler with Integrated Sensors

, ORCID Icon, , , , , , , , & show all
Pages 1623-1637 | Received 09 Jul 2022, Accepted 02 Nov 2022, Published online: 11 Nov 2022

References

  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2020. Available from: www.ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed October 05, 2022.
  • Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105:930–938. doi:10.1016/j.rmed.2011.01.005
  • Lavorini F, Usmani OS. Correct inhalation technique is critical in achieving good asthma control. Prim Care Respir J. 2013;22:385–386. doi:10.4104/pcrj.2013.00097
  • Wright J, Brocklebank D, Ram F. Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD). Qual Saf Health Care. 2002;11:376–382. doi:10.1136/qhc.11.4.376
  • Usmani OS, Lavorini F, Marshall J, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19:10. doi:10.1186/s12931-017-0710-y
  • Price DB, Román-Rodríguez M, McQueen RB, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5(1071–1081.e9). doi:10.1016/j.jaip.2017.01.004
  • Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–1331. doi:10.1183/09031936.00166410
  • Atkins PJ. Dry powder inhalers: an overview. Respir Care. 2005;50:1304–12; discussion 1312.
  • Broeders MEAC, Molema J, Hop WCJ, Vermue NA, Folgering H. The course of inhalation profiles during an exacerbation of obstructive lung disease. Resp Med. 2004;98:1173–1179. doi:10.1016/j.rmed.2004.04.010
  • Teva Pharmaceuticals Digihaler inhalers. Available from: https://www.digihaler.com. Accessed October 05, 2022.
  • Chrystyn H, Saralaya D, Shenoy A, et al. Investigating the accuracy of the digihaler, a new electronic multidose dry-powder inhaler, in measuring inhalation parameters. J Aerosol Med Pulm Drug Deliv. 2022;35(3):166–177. doi:10.1089/jamp.2021.0031
  • National Heart, Lung, and Blood Institute, Expert Panel Report 3. Guidelines for the diagnosis and management of asthma full report 2007. National Asthma Education and Prevention Program; 2007. Available from: https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf. Accessed October 05, 2022.
  • Gupta S, Wan FT, Hall SE, Straus SE. An asthma action plan created by physician, educator and patient online collaboration with usability and visual design optimization. Respiration. 2012;84:406–415. doi:10.1159/000338112
  • Kouri A, Boulet LP, Kaplan A, Gupta S. An evidence-based, point-of-care tool to guide completion of asthma action plans in practice. Eur Respir J. 2017;49:1602238. doi:10.1183/13993003.02238-2016
  • Gupta S, Kaplan A. Solving the mystery of the yellow zone of the asthma action plan. NPJ Prim Care Respir Med. 2018;28:1. doi:10.1038/s41533-017-0067-1
  • Than MP, Pickering JW, Sandoval Y, et al. Machine learning to predict the likelihood of acute myocardial infarction. Circulation. 2019;140:899–909. doi:10.1161/CIRCULATIONAHA.119.041980
  • Stelhick J, Schmalfuss C, Bozkurt B, et al. Continuous wearable monitoring analytics predict heart failure hospitalization: the LINK-HF multicenter study. Circ Heart Fail. 2020;13(3):e006513. doi:10.1161/CIRCHEARTFAILURE.119.006513
  • Giannini HM, Ginestra JC, Chivers C, et al. A machine learning algorithm to predict severe sepsis and septic shock: development, implementation and impact on clinical practice. Crit Care Med. 2019;47(11):1485–1492. doi:10.1097/CCM.0000000000003891
  • Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542:115–118. doi:10.1038/nature21056
  • Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316(22):2402–2410. doi:10.1001/jama.2016.17216
  • Ghahramani Z. Probabilistic machine learning and artificial intelligence. Nature. 2015;521(7553):452–459. doi:10.1038/nature14541
  • Deo RC. Machine learning in medicine. Circulation. 2015;132:1920–1930. doi:10.1161/CIRCULATIONAHA.115.001593
  • Kingsford C, Salzberg SL. What are decision trees? Nat Biotechnol. 2008;26:1011–1013. doi:10.1038/nbt0908-1011
  • Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29:1189–1232. doi:10.1214/aos/1013203451
  • Bateman ED, Buhl R, O’Byrne PM, et al. Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations. J Allergy Clin Immunol. 2015;135(1457–1464.e4):1457–1464.e4. doi:10.1016/j.jaci.2014.08.015
  • Finkelstein J, Jeong IC. Machine learning approaches to personalize early prediction of asthma exacerbations. Ann N Y Acad Sci. 2017;1387:153–165. doi:10.1111/nyas.13218
  • Messinger AI, Deterding RR, Szefler SJ. Bringing technology to day-to-day asthma management. Am J Respir Crit Care Med. 2018;198:291–292. doi:10.1164/rccm.201805-0845ED
  • Korn S, Both J, Jung M, Hübner M, Taube C, Buhl R. Prospective evaluation of current asthma control using ACQ and ACT compared with GINA criteria. Ann Allergy Asthma Immunol. 2011;107:474–479. doi:10.1016/j.anai.2011.09.001
  • Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59–99. doi:10.1164/rccm.200801-060ST
  • Chen T, Guestrin C. Xgboost: a scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; 2016:785–794.
  • Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett. 2006;27(8):861–874. doi:10.1016/j.patrec.2005.10.010
  • Honkoop PJ, Taylor DR, Smith AD, Snoeck-Stroband JB, Sont JK. Early detection of asthma exacerbations by using action points in self-management plans. Eur Respir J. 2013;41:53–59. doi:10.1183/09031936.00205911
  • Amin S, Soliman M, McIvor A, Cave A, Cabrera C. Usage patterns of short-acting β2-agonists and inhaled corticosteroids in asthma: a targeted literature review. J Allergy Clin Immunol Pract. 2020;8(8):2556–2564.e8. doi:10.1016/j.jaip.2020.03.013
  • Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55:1901872. doi:10.1183/13993003.01872-2019
  • Azzi EA, Kritikos V, Peters MJ, et al. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey. BMJ Open. 2019;9:e028995. doi:10.1136/bmjopen-2019-028995
  • Centers for Disease Control and Prevention. Uncontrolled asthma among persons with current asthma; 2014. Available from: http://www.cdc.gov/asthma/asthma_stats/uncontrolled_asthma.htm. Accessed October 05, 2022.
  • European Lung White Book. The economic burden of lung disease; 2019. Available from: http://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease. Accessed October 05, 2022.
  • Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest. 2002;121:329–333. doi:10.1378/chest.121.2.329
  • Azouza W, Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J. 2012;21:208–213. doi:10.4104/pcrj.2012.00010
  • Papiris S, Kotanidou A, Malagari K, Roussos C. Clinical review: severe asthma. Crit Care. 2002;6:30–44. doi:10.1186/cc1451
  • Chung K-F. Personalised medicine in asthma: the time for action. Eur Respir Rev. 2017;26:170064. doi:10.1183/16000617.0064-2017
  • Kocsis O, Lalos A, Arvanitis G, Moustakas K. Multi-model short-term prediction schema for mHealth empowering asthma self-management. Electron Notes Theor Comput Sci. 2019;343:3–17. doi:10.1016/j.entcs.2019.04.007
  • FDA. Proposed regulatory framework for modifications to artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD). Available from: https://www.fda.gov/files/medical%20devices/published/US-FDA-Artificial-Intelligence-and-Machine-Learning-Discussion-Paper.pdf. Accessed October 05, 2022.
  • Cosgriff CV, Celi LA, Sauer CM. Boosting clinical decision-making: machine learning for intensive care unit discharge. Ann Am Thorac Soc. 2018;15(7):804–805. doi:10.1513/AnnalsATS.201803-205ED
  • Patel M, Pilcher J, Reddel HK, et al. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma. J Allergy Clin Immunol Pract. 2014;2:751–758. doi:10.1016/j.jaip.2014.06.001
  • Mahler DA, Waterman LA, Gifford AH. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus dry powder inhaler. J Aerosol Med Pulm Drug Deliv. 2013;26:174–179. doi:10.1089/jamp.2012.0987